Quality Improvement of Patient-Provider Communication For Colorectal Cancer Screening

In the United States, colorectal cancer is the third most common cancer and the second leading cause of cancer mortality with over 56,000 deaths in 2004). Early detection through screening decreases the mortality associated with the disease. However, adherence with current screening recommendations is low. A survey of the general population indicates that only 53.1% of Americans, age 50 years and older for whom colorectal cancer screening is recommended, are up-to-date with this preventive service. While colorectal cancer screening rates with the VA Healthcare System (VHA) are better than in the general population (75% in Fiscal Year (FY) 2005), they are lower than performance rates for other types of cancer screening (e.g., mammography) in VHA. Further, numerous VA medical centers report colorectal cancer screening rates below the level considered satisfactory.

Inclusion criteria

Provider Eligibility:

• Primary care providers (MD, Certified Registered Nurse Practitioner (CRNP), or PA) at the study sites who see patients in the primary care setting at least 1 day per week and had no involvement in the design of the study are eligible for enrollment in the study.

Patient Eligibility:

• Primary care patients who are not "up-to-date" with colorectal cancer screening are the targeted population for study enrollment.
• Up-to-date with colorectal cancer screening is defined as having completed one of the following:

• fecal occult blood testing within the past year
• sigmoidoscopy within the past 5 years
• colonoscopy within the past 10 years
• barium enema within the past 5 years.
• Other patient eligibility criteria are:

• Primary Care Provider (PCP) enrolled in the study
• clinic visit scheduled with the enrolled PCP during the recruitment period
• English speaking
• no prior history of colorectal cancer or adenomatous polyps
• no prior history of inflammatory bowel disease

Exclusion criteria

• Patients who are deemed clinically not appropriate for colorectal cancer screening due to severe comorbidity and/or limited life expectancy as determined by the patient's primary care provider will be excluded from the study.